Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Sep 20, 2025; 15(3): 100332
Published online Sep 20, 2025. doi: 10.5662/wjm.v15.i3.100332
Interaction between gut virome and microbiota on inflammatory bowel disease
Xiao-Long Li, Mueen Megdadi, Humair S Quadri
Xiao-Long Li, Mueen Megdadi, Humair S Quadri, Department of Surgery, Ascension St Agnes Hospital, Baltimore, MD 21009, United States
Co-corresponding authors: Xiao-Long Li and Humair S Quadri.
Author contributions: Li XL designed the overall concept and outline of the manuscript; Quadri HS contributed to the discussion of the manuscript; Li XL and Quadri HS contributed equally as co-corresponding authors; Li XL and MM contributed to the writing, and editing the manuscript, illustrations, and review of literature.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Long Li, MD, PhD, Surgeon, Department of Surgery, Ascension St Agnes Hospital, 900 S Caton Ave, Baltimore, MD 21009, United States. li.xiaolong@ascension.org
Received: August 13, 2024
Revised: December 31, 2024
Accepted: January 15, 2025
Published online: September 20, 2025
Processing time: 204 Days and 9.8 Hours
Core Tip

Core Tip: The gut virome plays a crucial role in inflammatory bowel disease (IBD) pathogenesis, bacterial community dynamics, and immune responses. Alterations in virome composition in IBD patients, characterized by increased Caudovirales and decreased Microviridae phages, contribute to dysbiosis and inflammation. Understanding these interactions may reveal novel therapeutic targets for IBD.